Multiple Sclerosis Clinical Trials Database - Free Access to 1,606 Studies
Access comprehensive clinical trial information for Multiple Sclerosis through Pure Global AI's free database. This collection includes 1,606 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 286 trials are actively recruiting participants.
Research for Multiple Sclerosis is being conducted in United States of America, France, Turkey and 7+ other countries. Leading sponsors include Biogen and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Implementation of Online Mindfulness-Based Stress Reduction Tailored for People With Multiple Sclerosis
Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis
Propionic Acid in Multiple Sclerosis
Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis
Effects of Balance Exercises Performed With Different Visual Stimuli
Improving the Effect of Multiple Sclerosis Drugs by Chronobiology
Resistance Training and Corticospinal Excitability in Multiple Sclerosis
Effects of Head and Neck Cooling and Heating on Fatigue in Multiple Sclerosis and Healthy Men
Effectiveness of the EXOPULSE Mollii Ⓡ Suit in Patients With Multiple Sclerosis
Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve
Oral Cladribine B-cell Study
Traditional Versus Progressive Robot-assisted Gait Training in People With Multiple Sclerosis and Severe Gait Disability
Kappa Index Versus Csf Oligoclonal Bands in Diagnosis of ms and Prediction of Disease Activity
Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis
Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis
Functional Balance Intervention in Multiple Sclerosis
Trunk Control and Disability in Persons With Multiple Sclerosis
Social and Moral Cognition in Multiple Sclerosis
ADAs to Alemtuzumab
Pure Global AI provides free access to 1,606 clinical trials studying Multiple Sclerosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Biogen, Novartis Pharmaceuticals, Bayer, among others.